These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need? Lim S. Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878 [Abstract] [Full Text] [Related]
14. Aldosterone and spironolactone in heart failure. Weber KT. N Engl J Med; 1999 Sep 02; 341(10):753-5. PubMed ID: 10471464 [No Abstract] [Full Text] [Related]
15. Effect of spironolactone on urinary protein excretion in patients with chronic kidney disease. Sengul E, Sahin T, Sevin E, Yilmaz A. Ren Fail; 2009 Sep 02; 31(10):928-32. PubMed ID: 20030528 [Abstract] [Full Text] [Related]
16. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia. Cruz CS, Cruz LS, Domingues GS, Souza CA. Expert Opin Drug Saf; 2005 Jul 02; 4(4):677-88. PubMed ID: 16011447 [Abstract] [Full Text] [Related]
18. Effects of spironolactone in combination with angiotensin-converting enzyme inhibitors or Angiotensin receptor blockers in patients with proteinuria. Kim HY, Bae EH, Ma SK, Kim SW. Kidney Blood Press Res; 2014 Jul 02; 39(6):573-80. PubMed ID: 25531940 [Abstract] [Full Text] [Related]